Literature DB >> 23006214

Serum-free medium and mesenchymal stromal cells enhance functionality and stabilize integrity of rat hepatocyte spheroids.

Ji Bao1, James E Fisher, Joseph B Lillegard, William Wang, Bruce Amiot, Yue Yu, Allan B Dietz, Yaakov Nahmias, Scott L Nyberg.   

Abstract

Long-term culture of hepatocyte spheroids with high ammonia clearance is valuable for therapeutic applications, especially the bioartificial liver. However, the optimal conditions are not well studied. We hypothesized that liver urea cycle enzymes can be induced by high protein diet and maintain on a higher expression level in rat hepatocyte spheroids by serum-free medium (SFM) culture and coculture with mesenchymal stromal cells (MSCs). Rats were feed normal protein diet (NPD) or high protein diet (HPD) for 7 days before liver digestion and isolation of hepatocytes. Hepatocyte spheroids were formed and maintained in a rocked suspension culture with or without MSCs in SFM or 10% serum-containing medium (SCM). Spheroid viability, kinetics of spheroid formation, hepatic functions, gene expression, and biochemical activities of rat hepatocyte spheroids were tested over 14 days of culture. We observed that urea cycle enzymes of hepatocyte spheroids can be induced by high protein diet. SFM and MSCs enhanced ammonia clearance and ureagenesis and stabilized integrity of hepatocyte spheroids compared to control conditions over 14 days. Hepatocytes from high protein diet-fed rats formed spheroids and maintained a high level of ammonia detoxification for over 14 days in a novel SFM. Hepatic functionality and spheroid integrity were further stabilized by coculture of hepatocytes with MSCs in the spheroid microenvironment. These findings have direct application to development of the spheroid reservoir bioartificial liver.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23006214      PMCID: PMC3781336          DOI: 10.3727/096368912X656054

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  24 in total

1.  Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions.

Authors:  Rachel Glicklis; Jose C Merchuk; Smadar Cohen
Journal:  Biotechnol Bioeng       Date:  2004-06-20       Impact factor: 4.530

Review 2.  Preparation of isolated rat liver cells.

Authors:  P O Seglen
Journal:  Methods Cell Biol       Date:  1976       Impact factor: 1.441

Review 3.  Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems.

Authors:  J Tsiaoussis; P N Newsome; L J Nelson; P C Hayes; J N Plevris
Journal:  Liver Transpl       Date:  2001-01       Impact factor: 5.799

4.  Structural polarity and functional bile canaliculi in rat hepatocyte spheroids.

Authors:  Susan Fugett Abu-Absi; Julie R Friend; Linda K Hansen; Wei-Shou Hu
Journal:  Exp Cell Res       Date:  2002-03-10       Impact factor: 3.905

5.  Normal atmospheric oxygen tension and the use of antioxidants improve hepatocyte spheroid viability and function.

Authors:  Joseph B Lillegard; James E Fisher; Geir Nedredal; Jennifer Luebke-Wheeler; Ji Bao; William Wang; Bruce Amoit; Scott L Nyberg
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

6.  Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.

Authors:  Achilles A Demetriou; Robert S Brown; Ronald W Busuttil; Jeffrey Fair; Brendan M McGuire; Philip Rosenthal; Jan Schulte Am Esch; Jan Lerut; Scott L Nyberg; Mauro Salizzoni; Elizabeth A Fagan; Bernard de Hemptinne; Christoph E Broelsch; Maurizio Muraca; Joan Manuel Salmeron; John M Rabkin; Herold J Metselaar; Daniel Pratt; Manuel De La Mata; Lawrence P McChesney; Gregory T Everson; Philip T Lavin; Anthony C Stevens; Zorina Pitkin; Barry A Solomon
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

7.  Engineering analysis and development of the spheroid reservoir bioartificial liver.

Authors:  Malcolm B McIntosh; Stephen M Corner; Bruce P Amiot; Scott L Nyberg
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

8.  Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact.

Authors:  J Michael Millis; David C Cronin; Robert Johnson; Hari Conjeevaram; Carol Conlin; Sharon Trevino; Patrick Maguire
Journal:  Transplantation       Date:  2002-12-27       Impact factor: 4.939

9.  Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy.

Authors:  J Denis; M L Delorme; M Boschat; B Nordlinger; P Opolon
Journal:  J Neurochem       Date:  1983-01       Impact factor: 5.372

10.  Induction of urea cycle enzymes of rat liver by glucagon.

Authors:  P J Snodgrass; R C Lin; W A Müller; T T Aoki
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

View more
  11 in total

1.  Microfluidic Chip as a Tool for Effective In Vitro Evaluation of Cyclophosphamide Prodrug Toxicity.

Authors:  N V Pulkova; A N Zyrina; N A Mnafki; I M Kuznetsova
Journal:  Bull Exp Biol Med       Date:  2022-05-28       Impact factor: 0.804

2.  Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism.

Authors:  Yi Wang; Le Chang; Jiahui Zhai; Qiao Wu; Donggen Wang; Yunfang Wang
Journal:  J Cell Mol Med       Date:  2017-05-30       Impact factor: 5.310

3.  Construction of a general albumin promoter reporter system for real-time monitoring of the differentiation status of functional hepatocytes from stem cells in mouse, rat and human.

Authors:  Jing Tang; Qiong Wu; Yi Li; Xiujuan Wu; Yujia Wang; Lihua Zhu; Yujun Shi; Hong Bu; Ji Bao; Mingjun Xie
Journal:  Biomed Rep       Date:  2017-05-03

4.  Hemocompatibility improvement of perfusion-decellularized clinical-scale liver scaffold through heparin immobilization.

Authors:  Ji Bao; Qiong Wu; Jiu Sun; Yongjie Zhou; Yujia Wang; Xin Jiang; Li Li; Yujun Shi; Hong Bu
Journal:  Sci Rep       Date:  2015-06-01       Impact factor: 4.379

5.  Novel spheroid reservoir bioartificial liver improves survival of nonhuman primates in a toxin-induced model of acute liver failure.

Authors:  Yi Li; Qiong Wu; Yujia Wang; Chengxin Weng; Yuting He; Mengyu Gao; Guang Yang; Li Li; Fei Chen; Yujun Shi; Bruce P Amiot; Scott L Nyberg; Ji Bao; Hong Bu
Journal:  Theranostics       Date:  2018-11-09       Impact factor: 11.556

6.  Optimizing perfusion-decellularization methods of porcine livers for clinical-scale whole-organ bioengineering.

Authors:  Qiong Wu; Ji Bao; Yong-jie Zhou; Yu-jia Wang; Zheng-gui Du; Yu-jun Shi; Li Li; Hong Bu
Journal:  Biomed Res Int       Date:  2015-03-31       Impact factor: 3.411

7.  Genipin crosslinking reduced the immunogenicity of xenogeneic decellularized porcine whole-liver matrices through regulation of immune cell proliferation and polarization.

Authors:  Yujia Wang; Ji Bao; Xiujuan Wu; Qiong Wu; Yi Li; Yongjie Zhou; Li Li; Hong Bu
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

8.  Enhanced hepatic differentiation of rat bone marrow-derived mesenchymal stem cells in spheroidal aggregate culture on a decellularized liver scaffold.

Authors:  Ji Bao; Qiong Wu; Yujia Wang; Yi Li; Li Li; Fei Chen; Xiujuan Wu; Mingjun Xie; Hong Bu
Journal:  Int J Mol Med       Date:  2016-06-14       Impact factor: 4.101

9.  Hepatocyte isolation from resected benign tissues: Results of a 5-year experience.

Authors:  Fan-Ying Meng; Li Liu; Jun Liu; Chun-You Li; Jian-Ping Wang; Feng-Hui Yang; Zhi-Shui Chen; Ping Zhou
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

10.  Hepatic differentiation of mouse bone marrow‑derived mesenchymal stem cells using a novel 3D culture system.

Authors:  Qiong Wu; Jing Tang; Yi Li; Li Li; Yujia Wang; Ji Bao; Hong Bu
Journal:  Mol Med Rep       Date:  2017-10-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.